Humidity and Bland Aerosol Therapy

Published on 01/06/2015 by admin

Filed under Pulmolory and Respiratory

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 10117 times

Humidity and Bland Aerosol Therapy

Jim Fink and Arzu Ari

Vapors and mists have been used for thousands of years to treat respiratory disease. Modern respiratory care still uses these treatments at the bedside, in the form of water vapor (humidity) and bland water aerosols. Concepts of absolute and relative humidity are essential for understanding humidity therapy; these concepts are covered in Chapter 6. This chapter reviews the principles, methods, equipment, and procedures for using these concepts appropriately.

Humidity Therapy

Humidity therapy involves adding water vapor and (sometimes) heat to the inspired gas. To understand the need for humidity therapy, clinicians first must understand the normal control of heat and moisture exchange.

Physiologic Control of Heat and Moisture Exchange

Heat and moisture exchange is a primary function of the upper respiratory tract, mainly the nose.1 The nose heats and humidifies gas on inspiration and cools and reclaims water from gas that is exhaled. The nasal mucosal lining is kept moist by secretions from mucous glands, goblet cells, transudation of fluid through cell walls, and condensation of exhaled humidity. The nasal mucosa is very vascular, actively regulating temperature changes in the nose and serving as an active element in promoting effective heat transfer. Similarly, the mucosa lining the sinuses, trachea, and bronchi aid in heating and humidifying inspired gases.

During inspiration through the nose, the tortuous path of gas through the turbinates increases contact between the inspired air and the mucosa. As the inspired air enters the nose, it warms (convection) and picks up water vapor from the moist mucosal lining (evaporation), cooling the mucosal surface.

During exhalation, the expired gas transfers heat back to the cooler tracheal and nasal mucosa by convection. As the saturated gas cools, it holds less water vapor. Condensation occurs on the mucosal surfaces during exhalation, and water is reabsorbed by the mucus (rehydration). In cold environments, the formation of condensate may exceed the ability of the mucus to reabsorb water (resulting in a “runny nose”).

The mouth is less effective at heat and moisture exchange than the nose because of the low ratio of gas volume to moist and warm surface area and the less vascular squamous epithelium lining the oropharynx and hypopharynx. When a person inhales through the mouth at normal room temperature, pharyngeal temperatures are approximately 3° C less than when the person breathes through the nose, with 20% less relative humidity. During exhalation, the relative humidity of expired gas varies little between mouth breathing and nose breathing, but the mouth is much less efficient in reclaiming heat and water.2

As inspired gas moves into the lungs, it achieves BTPS conditions (body temperature, 37° C; barometric pressure; saturated with water vapor [100% relative humidity at 37° C]) (Figure 35-1). This point, normally approximately 5 cm below the carina, is called the isothermic saturation boundary (ISB).3 Above the ISB, temperature and humidity decrease during inspiration and increase during exhalation. Below the ISB, temperature and relative humidity remain constant (BTPS).

Numerous factors can shift the ISB deeper into the lungs. The ISB shifts distally when a person breathes through the mouth rather than the nose; when the person breathes cold, dry air; when the upper airway is bypassed (breathing through an artificial tracheal airway); or when the minute ventilation is higher than normal. When this shift of ISB occurs, additional surfaces of the airway are recruited to meet the heat and humidity requirements of the lung. This recruitment of airways that do not typically provide this level of heat and humidity can have a negative impact on epithelial integrity. These shifts of the ISB can compromise the body’s normal heat and moisture exchange mechanisms, and humidity therapy is indicated.

Indications for Humidification and Warming of Inspired Gases

The primary goal of humidification is to maintain normal physiologic conditions in the lower airways. Proper levels of heat and humidity help ensure normal function of the mucociliary transport system. Humidity therapy is also used to treat abnormal conditions. Box 35-1 summarizes the primary and secondary indications for humidity therapy.

Administration of dry medical gases at flows greater than 4 L/min to the upper airway causes immediate heat and water loss and, if prolonged, causes structural damage to the epithelium. As the airway is exposed to relatively cold, dry air, ciliary motility is reduced, airways become more irritable, mucus production increases, and pulmonary secretions become inspissated (thickened owing to dehydration).

The hazard of breathing dry gas is even greater when the normal heat and water exchange capabilities of the upper airway are lost or bypassed, as occurs with endotracheal intubation.4 Breathing dry gas through an endotracheal tube can cause damage to tracheal epithelium within minutes. However, as long as the inspired humidity is at least 60% of BTPS conditions, no injury occurs in normal lungs.5,6 Prolonged breathing of improperly conditioned gases through a tracheal airway can result in hypothermia (reduced body temperature), inspissation of airway secretions, mucociliary dysfunction, destruction of airway epithelium, and atelectasis.7 Box 35-2 summarizes the signs and symptoms associated with breathing cold, dry gases.

Figure 35-2 illustrates the level of dysfunction in the airway caused by changes in absolute humidity below BTPS and over hours of exposure. A reduction of 20 mg/L below BTPS (44 mg/L) is less than 60% relative humidity at BTPS.

The amount of heat and humidity that a patient needs depends on the site of gas delivery (e.g., nose or mouth, hypopharynx, trachea). Table 35-1 summarizes the recommended levels based on current standards.8

TABLE 35-1

Recommended Heat and Humidity Levels

Delivery Site Temperature Range (° C) Relative Humidity (%) Absolute Humidity (mg/L)
Nose/mouth 20-22 50 10
Hypopharynx 29-32 95 28-34
Trachea 32-35 100 36-40

image

From Chatburn R, Primiano F: A rational basis for humidity therapy. Respir Care 32:249, 1987.

Warmed, humidified gases are used to prevent or treat various abnormal conditions. For treatment of a patient with hypothermia, heating and humidifying the inspired gas is one of several techniques used to raise core temperatures back to normal.9,10 Heated humidification is also used to prevent intraoperative hypothermia.11 Of possibly greater clinical significance, warming and humidifying the inspired gas can help alleviate bronchospasm in patients who develop airway narrowing after exercise or when they breathe cold air. Although the cause of this condition is not known for certain, the primary stimulus is probably a combination of airway cooling and drying, which leads to hypertonicity of airway lining fluid and the release of chemical mediators.12 Patients may reduce the incidence of cold air–induced bronchospasm by simply wearing a scarf over the nose and mouth when outside in cold weather; the scarf serves as a crude passive heat and moisture exchanger (HME).

The delivery of cool humidified gas is used to treat upper airway inflammation resulting from croup, epiglottitis, and postextubation edema. This technique is used most often in conjunction with bland aerosol delivery (see the section on Bland Aerosol Delivery).

Equipment

A humidifier is a device that adds molecular water to gas. This process occurs by evaporation of water from a surface (see Chapter 6), whether the water is in a reservoir, a wick, or a sphere of water in suspension (aerosol).

Physical Principles Governing Humidifier Function

The following four variables or principles affect the quality of performance of a humidifier: (1) temperature, (2) surface area, (3) time of contact, and (4) thermal mass. These factors are exploited to various degrees in the design of humidification devices (Box 35-3).

Temperature

Temperature is an important factor affecting humidifier performance. The greater the temperature of a gas, the more water vapor it can hold (increased capacity). As gas expansion and evaporation cool water in unheated humidifiers to 10° C below ambient temperature, the humidifiers become less efficient.

Figure 35-3 shows this concept, where, owing to evaporative cooling, the unheated humidifier on the left is operating at 10° C. Although the humidifier fully saturates the gas, the low operating temperature limits total water vapor capacity to approximately 9.4 mg/L water vapor, equivalent to approximately 21% of body humidity. Simply heating the humidifier to 40° C (see Figure 35-3, right) increases its output to 51 mg/L, which is sufficient to meet BTPS conditions.

Surface Area

The greater the area of contact between water and gas, the more opportunity there is for evaporation to occur. Passover humidifiers pass gas over a large surface area of water. More space-efficient ways to increase the water/gas surface-area ratio include bubble diffusion, aerosol, and wick technologies.

The bubble-diffusion technique directs a stream of gas underwater, where it is broken up into small bubbles. As the gas bubbles rise to the surface, evaporation increases the water vapor content within the bubble. The smaller the bubble, the greater the water/air surface-area ratio.

An alternative to dispersing gas bubbles in water is spraying water particles into the gas. This is accomplished by generating an aerosol (suspension of water droplets) in the gas stream. The higher the aerosol density (number of particles per volume of gas), the greater the gas/water surface area available for evaporation.

Wick technologies use porous water-absorbent materials to increase surface area. A wick draws water (similar to a sponge) into its fine honeycombed structure by means of capillary action. The surfaces of the wick increase the area of contact between the water and gas, which aids evaporation.

Types of Humidifiers

Humidifiers are either active (actively adding heat or water or both to the device-patient interface) or passive (recycling exhaled heat and humidity from the patient). Active humidifiers typically include (1) bubble humidifiers, (2) passover humidifiers, (3) nebulizers of bland aerosols, and (4) vaporizers. Passive humidifiers refer to typical heat and moisture exchangers (HMEs). Specifications covering the design and performance requirements for medical humidifiers are established by the American Society for Testing and Materials (ASTM).13

Active Humidifiers

Bubble

A bubble humidifier breaks (diffuses) an underwater gas stream into small bubbles (Figure 35-4). Use of a foam or mesh diffuser produces smaller bubbles than an open lumen, allowing greater surface area for gas/water interaction. Unheated bubble humidifiers are commonly used with oxygen (O2) delivery systems (see Chapter 38) to raise the water vapor content of the gas to ambient levels.

As indicated in Table 35-2, unheated bubble humidifiers can provide absolute humidity levels between approximately 15 mg/L and 20 mg/L.1416 At room temperature, 10 mg/L absolute humidity corresponds to approximately 80% relative humidity but only approximately 25% body humidity (see Chapter 6). As gas flow increases, these devices become less efficient as the reservoir cools and contact time is reduced, limiting their effectiveness at flow rates greater than 10 L/min. Heating the reservoirs of these units can increase humidity content, but this is not recommended because the resulting condensate tends to obstruct the small bore delivery tubing to which these units connect.

TABLE 35-2

Absolute Humidity (mg/L) Provided by Unheated Bubble Humidifiers

L/min Aquapak 301 (Hudson RCI, Corp, Dunham, NC) Traveral 500 (Baxter-Travenol, Corp, Deerfield, IL)
2 17.6 20.4
4 17.7 19.5
6 16.9 16.2
8 14.9 15.7

Modified from Darin J, Broadwell J, MacDonell R: An evaluation of water-vapor output from four brands of unheated, prefilled bubble humidifiers. Respir Care 27:41, 1982.

To warn of flow-path obstruction and to prevent bursting of the humidifier bottle, bubble humidifiers incorporate a simple pressure-relief valve, or pop-off. Typically, the pop-off is either a gravity or spring-loaded valve that releases pressures greater than 2 psi. Humidifier pop-offs should provide both an audible and a visible alarm and should automatically resume normal position when pressures return to normal.13 The pop-off also can be used to test an O2 delivery system for leaks. If the system is obstructed at or near the patient interface and the pop-off sounds, the system is leak-free; failure of the pop-off to sound may indicate a leak (or a faulty pop-off valve).

At high flow rates, bubble humidifiers can produce aerosols. Although invisible to the naked eye, these water droplet suspensions can transmit pathogenic bacteria from the humidifier reservoir to the patient.17 Because any device that generates an aerosol poses a high risk of spreading infection, strict infection control procedures must be followed when using these systems (see Chapter 4).

Passover

Passover humidifiers direct gas over a surface containing water. There are three common types of passover humidifiers: (1) simple reservoir type, (2) wick type, and (3) membrane type (see Figure 35-4).

The simple reservoir device directs gas over the surface of a volume of water (or fluid). The surface for gas-fluid interface is limited. These systems are typically used with heated fluids for use with mechanical ventilation, but they may also be used with room temperature fluids with noninvasive ventilatory support (nasal continuous positive airway pressure or bilevel ventilation).

A wick humidifier uses an absorbent material to increase the surface area for dry air to interface with heated water. Typically, a wick is placed upright with the gravity-dependent end in a heated water reservoir. Heating elements might be below or surrounding the wick. Capillary action continually draws water up from the reservoir and keeps the wick saturated. As dry gas enters the chamber, it flows around the wick, quickly picking up heat and moisture and leaving the chamber fully saturated with water vapor. No bubbling occurs, so no aerosol is produced.

A membrane-type humidifier separates the water from the gas stream by means of a hydrophobic membrane (see Figure 35-4). Water vapor molecules can easily pass through this membrane, but liquid water (and pathogens) cannot. As with a wick humidifier, bubbling does not occur. If a membrane-type humidifier were to be inspected while it was in use, no liquid water would be seen in the humidifier chamber.

Compared with bubble humidifiers, passover humidifiers offer several advantages.17,18 First, in contrast to bubble devices, passover humidifiers can maintain saturation at high flow rates. Second, they add little or no flow resistance to spontaneous breathing circuits. Third, they do not generate any aerosols, and they pose a minimal risk for spreading infection.

Heat and Moisture Exchangers

An HME is most often a passive humidifier, also described as an “artificial nose.” Similar to the nose, an HME captures exhaled heat and moisture and uses it to heat and humidify the next inspiration. In contrast to the nose, with its rich vasculature and endothelium, most HMEs do not actively add heat or water to the system. A typical HME is a passive humidifier, capturing both heat and moisture from expired gas and returning up to 70% of both to the patient during the next inspiration.

Traditionally, use of HMEs has been limited to providing humidification to patients receiving invasive ventilatory support via endotracheal or tracheostomy tubes. More recently, HMEs have been used successfully in meeting the short-term humidification needs of spontaneously breathing patients with tracheostomy tubes.19 Kapadia20 reviewed airway accidents in the intensive care unit for a 4-year period and noted an increasing trend in the incidence of blocked tracheal tubes, which was associated with an increased duration of HME filter use. More recent evidence supports long-term use of HMEs for spontaneously breathing patients.21

The three basic types of HMEs are (1) simple condenser humidifiers, (2) hygroscopic condenser humidifiers, and (3) hydrophobic condenser humidifiers. Simple condenser humidifiers contain a condenser element with high thermal conductivity, usually consisting of metallic gauze, corrugated metal, or parallel metal tubes. On inspiration, inspired air cools the condenser element. On exhalation, expired water vapor condenses directly on its surface and rewarms it. On the next inspiration, cool, dry air is warmed and humidified as its passes over the condenser element. Simple condenser humidifiers are able to recapture only approximately 50% of a patient’s exhaled moisture (50% efficiency).

Hygroscopic condenser humidifiers provide higher efficiency by (1) using a condensing element of low thermal conductivity (e.g., paper, wool, foam) and (2) impregnating this material with a hygroscopic salt (calcium or lithium chloride). By using an element with low thermal conductivity, hygroscopic condenser humidifiers can retain more heat than simple condenser systems. In addition, the hygroscopic salt helps capture extra moisture from the exhaled gas. During exhalation, some water vapor condenses on the cool condenser element, whereas other water molecules bind directly to the hygroscopic salt. During inspiration, the lower water vapor pressure in the inspired gas liberates water molecules directly from the hygroscopic salt, without cooling. Figure 35-5 depicts the overall process of humidification with a hygroscopic condenser humidifier, showing the changes in temperature and the relative and absolute humidity occurring during the cycle of breathing. As shown, these devices typically achieve approximately 70% efficiency (40 mg/L exhaled, 27 mg/L returned).

image
FIGURE 35-5 Process of humidification with a hygroscopic condenser humidifier. AH, Absolute humidity; RH, relative humidity; T, temperature.

Hydrophobic condenser humidifiers use a water-repellent element with a large surface area and low thermal conductivity (Figure 35-6). During exhalation, the condenser temperature increases to approximately 25° C because of conduction and latent heat of condensation. On inspiration, cool gas and evaporation cools the condenser down to 10° C. This large temperature change results in the conservation of more water to be used in humidifying the next breath. The efficiency of these devices is comparable to hygroscopic condenser humidifiers (approximately 70%). However, some hydrophobic humidifiers that provide bacterial filtration may reduce the risk of pneumonia but be unsuitable for patients with limited respiratory reserve or who are prone to airway blockage because they may increase artificial airway occlusion.22,23

Design and performance standards for HMEs are set by the International Organization for Standardization (ISO).24 The ideal HME should operate at 70% efficiency or better (providing at least 30 mg/L water vapor); use standard connections; have a low compliance; and add minimal weight, dead space, and flow resistance to a breathing circuit.25 According to Lellouche and colleagues,26 HME performance varies from brand to brand, and only 37.5% of 32 HMEs tested in the study performed well. Table 35-3 compares performance of several commercially available HMEs according to their moisture output, flow resistance, and dead space.26

TABLE 35-3

Comparison of 25 Heat and Moisture Exchangers

Device Manufacturer Measured AH (mg H2O/L) AH/ml of Dead Space Measured Resistance at 60 L/min cm H2O
Hygrovent Peters 31.9 ± 0.6 0.34 1.8
Hygrobac Mallinckrodt 31.7 ± 0.7 0.33 2.1
Hygrovent S Peters 31.7 ± 0.5 0.58 2.8
Hygrobac S Mallinckrodt 31.2 ± 0.2 0.69 2.3
9000/100 Allégiance 31.2 ± 1.4 0.35 2.7
Servo Humidifier 172 Siemens 30.9 ± 0.3 0.56 NA
Humid Vent Filter Hudson 30.8 ± 0.3 0.88 2.3
Hygroster Mallinckrodt 30.7 ± 0.6 0.32 2.3
Humid Vent 2 Hudson 29.7 ± 0.4 1.03 NA
Servo Humidifier 162 Siemens 29.7 ± 0.8 0.78 NA
Humid Vent 2S Hudson 29.2 ± 0.4 1.01 NA
9040/01 Allégiance 28.6 ± 1.1 0.61 2.4
9000/01 Allégiance 28.5 ± 0.8 0.32 3.9
BB100E Pall 27.2 ± 0.7 0.32 1.4
BB100 Pall 26.8 ± 0.5 0.30 2.0
Stérivent Mallinckrodt 23.8 ± 0.9 0.26 1.9
Iso Gard Hepa Light Hudson 23.6 ± 0.3 0.47 2.4
Stérivent S Mallinckrodt 22.2 ± 0.2 0.36 1.7
BB25 Pall 19.6 ± 1.4 0.56 2.6
BB2000AP Pall 18.9 ± 0.4 0.54 3.1
Stérivent Mini Mallinckrodt 16.6 ± 1.0 0.47 2.2
4444/66 Allégiance 16.4 ± 0.6 0.35 3.4
4000/01 Allégiance 15.1 ± 0.9 0.40 2.2
Barrierbac S Mallinckrodt 13.2 ± 0.2 0.38 2.1

image

AH, Absolute humidity; NA, not available.

Modified from Lellouche F, Taille S, Lefrancois F, et al: Humidification performance of 48 passive airway humidifiers: comparison with manufacturer data. Chest 135:276, 2009.

As shown in Table 35-3, the moisture output of HMEs tends to decrease at high volumes and rates of breathing. In addition, high inspiratory flows and high FiO2 levels can decrease HME efficiency.25 Flow resistance through the HME also is important. When an HME is dry, resistance across most devices is minimal. However, because of water absorption, HME flow resistance increases after several hours of use.27,28 For some patients, the increased resistance imposed by the HME may not be well tolerated, in particular, if the underlying lung disease already causes increased work of breathing.

Because HMEs eliminate the problem of breathing circuit condensation, many clinicians consider these devices (especially hydrophobic filter HMEs) to be helpful in preventing nosocomial infections and ventilator-associated pneumonia.29 Compared with active humidification systems, HMEs do reduce bacterial colonization of ventilator circuits.30 However, circuit colonization plays a minor role in the development of nosocomial infections, provided that usual maintenance precautions are applied.31 Evidence indicates no difference in incidence of ventilator-associated pneumonia, mortality, morbidity, and respiratory complications among patients managed with HMEs and heated humidifiers.23,26,30,32,33

The position of the HME relative to the patient’s airway can affect its ability both to heat and to humidify inhaled gas. Secretions can foul HMEs attached directly to the airway. The use of devices such as closed suction catheters and airway monitor ports requires placement of the HME closer to the ventilator. Inui and colleagues34 tested performance of HMEs placed directly at the airway, 10 cm away from endotracheal tube and proximal to the ventilator circuit. HME performance was best at the airway for both HMEs tested, but one HME model exceeded recommended performance standards (≥30 mg/L absolute humidity and ≥30° C) at both sites, whereas the other model did not perform adequately at either position (Figure 35-7). Clinicians should select HMEs that perform adequately when placed at the intended HME site. Although use of HMEs has been associated with thickened and increased volume of secretions in some patients, the incidence of endotracheal tube occlusion when HMEs are used is lower than when heated humidifiers are used.35,36

HMEs are not recommended for use with infants for several reasons. First, HMEs add 30 to 90 ml of mechanical dead space, exceeding the tidal volume of the infant. In addition, infants are commonly ventilated through uncuffed endotracheal tubes, which allow exhaled gas to leak around the tube and bypass the HME reducing recovered heat and humidity.

Active Heat Moisture Exchangers

Active HMEs add humidity or heat or both to inspired gas by chemical or electrical means.37 The Humid-Heat (Louis Gibeck AB, Upplands Väsby, Sweden) consists of a supply unit with a microprocessor, water pump, and humidification device, which is placed between the Y-piece and the endotracheal tube. The humidification device is based on a hygroscopic HME, which absorbs the expired heat and moisture and releases it into the inspired gas. External heat and water are added to the patient side of the HME, so the inspired gas should reach 100% humidity at 37° C (44 mg H2O/L air). The external water is delivered to the humidification device via a pump onto a wick and evaporated into the inspired air by an electrical heater. The microprocessor controls the water pump and the heater by an algorithm using the minute ventilation (which is fed into the microprocessor) and the airway temperature measured by a sensor mounted in the flex-tube on the patient side of the humidification device. The HME Booster (King Systems, Noblesville, IN) has a T-piece containing an electrically heated element that was designed for use as an adjunct to a passive HME. The heating element heats water so that water vapor passes into the airway between the artificial airway and the endotracheal tube, via a Gore-Tex membrane and aluminum. Using a gravity feedbag via a flow regulator that limits flow to 10 mL/hr, water is fed to the heater, which operates at 110° C and adds 3 to 5.5 mg/L of humidity and 3° C to 4° C to inspired gas compared with HME alone. The Humid-Booster was designed for patients with minute volumes of 4 to 20 L, and it is not appropriate for use with pediatric patients or infants. Active HMEs add weight and complexity at the patient airway.

Heating Systems

Heat improves the water output of humidifiers. Heated humidifiers are used mainly for patients with bypassed upper airways and patients receiving mechanical ventilatory support. Although heating a humidifier provides benefits, it also presents additional risks. Humidifier heating systems generally have a controller that regulates the power to the heating element by monitoring the heating element, which matches a preset or an adjustable temperature. They may also use a thermistor placed at the outlet of the humidifier, with a heater set to control output temperature. Servo-controlled heating systems monitor the temperature at the humidifier’s outlet and at the patient’s airway using a thermistor probe. The controller adjusts the heater power to reach the desired airway temperature and incorporates alarms and an alarm-activated heater shutdown function.

An electrical heating element provides the needed energy. Five types of heating elements are common: (1) a hot plate element at the base of the humidifier; (2) a wraparound type that surrounds the humidifier chamber; (3) a yolk, or collar, element that sits between the water reservoir and the gas outlet; (4) an immersion-type heater, with the element placed in the water reservoir; (5) a heated wire in the inspiratory limb warming a saturated wick or hollow fiber; and (6) a thin-film, high surface area broiler.

Humidifier heating systems have a controller that regulates the element’s electrical power. In the simplest systems, the controller monitors the heating element, varying the delivered current to match either a preset or an adjustable temperature. In these systems, the temperature of the patient’s airway has no effect on the controller. Conversely, a servo-controlled heating system monitors temperature at or near the patient’s airway using a thermistor probe. The controller adjusts heater power to achieve the desired airway temperature. Both types of controller units usually incorporate alarms and alarm-activated heater shutdown. Box 35-4 outlines key features of modern heated humidification systems.38

Box 35-4

Key Features for Heated Humidification Systems

Gas temperature delivered to the patient should not be greater than 40° C. When temperatures greater than 40° C are reached, audible and visual alarms should indicate an over-temperature condition and interrupt power to the heater.

Audible and visual alarms should indicate when remote temperature sensors are disconnected, absent, or defective, and power to the heater should be interrupted to prevent overheating.

Temperature overshoot should be minimized. Overshoot can occur when servo-controlled units warm up without flow through the circuit, when the temperature probe is not inserted in the circuit (or becomes dislodged), or when flow changes during normal operation. Non–servo-controlled units can overshoot when temperature controls are set too high or when gas flow is abruptly reduced.

Indicators for delivered gas temperature should be accurate to ±3° C of the indicated value.

Humidifier temperature output should not vary more than 2° C from the set value (proximal to the patient).

Warm-up time should not exceed 15 minutes.

The water level should be readily visible in either the humidifier or the remote reservoir.

Humidifiers should be able to withstand ventilation pressures greater than 100 cm H2O.

Internal compliance should be low and stable so that changes in the water level do not significantly alter the delivered tidal volume.

The exposed surface of a humidifier should not be too hot to touch during operation. Readily accessible surfaces should not be greater than 37.5° C. A warning label is needed for hotter surfaces.

Operator, or feed, systems must not be able to overfill the humidifier to the point that water can block gas flow through the humidifier or ventilator circuit. Humidifiers should not be damaged by spilled fluids.

Electromagnetic interference from other devices should not affect humidifier performance. The unit should not be damaged by 95 to 135 V rms.

Fuses or circuit breakers should be clearly labeled and easily reset or replaced. The unit should have adequate overcurrent protection to prevent ventilator shutdown or loss of power to other equipment on the same branch circuit because of internal equipment failures.

It should be impossible to assemble the unit in a way that would be hazardous to the patient. The direction of gas flow should be indicated on interchangeable components, for which proper direction is essential.

The humidifier should be assembled and filled in a manner that minimizes the introduction of infectious materials or foreign objects.

Service and operation manuals should be provided with the humidifier and should cover all aspects of its use and service.

Modified from Emergency Care Research Institute: Heated humidifiers, Health Devices. 1987. http://www.fda.gov/oc/po/firmrecalls/Vapotherm2000i_01_06.html. Accessed March 2, 2011.

Reservoir and Feed Systems

Heated humidifiers operating continuously in breathing circuits can evaporate more than 1 L of water per day. To avoid constant refilling, these devices either incorporate a large water reservoir or use a gravity feed system. An ideal reservoir or feed system should be safe, dependable, and easy to set up and use and should allow for continuity of therapy, even when the reservoir is being replenished.

Manual Systems

Simple large reservoir systems are manually refilled (with sterile or distilled water). If a manual system is used, momentary interruption of humidifier operation and mechanical ventilation is required for refilling. Because the system must be “opened” for refilling, cross contamination can occur. Water levels in manually filled systems are constantly changing, and changes in the humidifier fill volume alter the gas compression factor and the delivered volume during mechanical ventilation.

A small inlet that can be attached to a gravity-fed intravenous bag and line allows refilling without interruption of ventilation. Such systems still require constant checking and manual replenishment by opening the line valve or clamp. If not checked regularly, the reservoir in these systems can go dry, placing the patient at considerable risk.

Automatic Systems

Automatic feed systems avoid the need for constant checking and manual refilling of humidifiers. The simplest type of automatic feed system is the level-compensated reservoir (Figure 35-8). In these systems, an external reservoir is aligned horizontally with the humidifier, maintaining relatively consistent water levels between the reservoir and the humidifier chamber.

Flotation valve controls can be used to maintain humidifier reservoir fluid volume. In flotation-type systems, a float rises and falls with the water level. As the water level falls below a preset value, the float opens the feed valve; as the water rises back to the set fill level, the float closes the feed valve. An optical sensor can also be used to sense water level, driving a solenoid valve to allow refilling of the humidifier reservoir.

Membrane-type humidifiers do not require a flow control system. Because the liquid water chamber underlying the membrane cannot overfill, these devices require only an open gravity feed system to ensure proper function. Two examples are the Vapotherm (Vapotherm Inc, Stevensville, MD) membrane cartridge system and the Hummax II (Metran Medical Instruments Mfg Co, Ltd, Saitama, Japan), which uses a heated wire to warm the polyethylene microporous hollow fiber placed in the inspiratory circuit.

The Hydrate (Pari Respiratory Equipment, Midlothian, VA) capillary force vaporizer is driven by software that controls a heater element and water flow. The 19-mm diameter disc can deliver 2.2 mg of water vapor/min at 37° C. Data from prototypes suggest temperature control from 33° C to 41° C for flows 2 to 40 L/min (Figure 35-9).39

To guide practitioners in applying humidity therapy during ventilatory support, the American Association for Respiratory Care (AARC) has published Clinical Practice Guideline: Humidification During Mechanical Ventilation; excerpts from the AARC guideline appear in Clinical Practice Guideline 35-1.7

35-1   Humidification During Mechanical Ventilation

AARC Clinical Practice Guideline (Excerpts)*

Hazards and Complications

Hazards and complications associated with the use of heated humidifier (HH) and HME devices during mechanical ventilation include the following:

• High flow rates during disconnect may aerosolize contaminated condensate (HH)

• Underhydration and mucous impaction (HME or HH)

• Increased work of breathing (HME or HH)

• Hypoventilation caused by increased dead space (HME)

• Elevated airway pressures caused by condensation (HH)

• Ineffective low-pressure alarm during disconnection (HME)

• Patient-ventilator dyssynchrony and improper ventilator function caused by condensation in the circuit (HH)

• Hypoventilation or gas trapping caused by mucous plugging (HME or HH)

• Hypothermia (HME or HH)

• Potential for burns to caregivers from hot metal (HH)

• Potential electrical shock (HH)

• Airway burns or tubing meltdown if heated wire circuits are covered or incompatible with humidifier (HH)

• Possible increased resistive work of breathing caused by mucous plugging (HME or HH)

• Inadvertent overfilling resulting in unintended tracheal lavage (HH)

• Inadvertent tracheal lavage from pooled condensate in circuit (HH)

Monitoring

The humidifier should be inspected during the patient-ventilator system check, and condensate should be removed from the circuit as needed. HMEs should be inspected and replaced if secretions have contaminated the insert or filter. The following should be recorded during equipment inspection:

• During routine use on an intubated patient, an HH should be set to deliver inspired gas at 33° C ± 2° C and should provide a minimum of 30 mg/L of water vapor.

• Inspired gas temperature should be monitored at or near the patient’s airway opening (HH).

• Specific temperatures may vary with the patient’s condition; airway temperature should never exceed 37° C.

• For heated wire circuits used with infants, the probe must be placed outside the incubator or away from the radiant warmer.

• The high-temperature alarm should be set no higher than 37° C, and the low setting should not be less than 30° C.

• Water level and function of automatic feed system (if applicable) should be monitored.

• Quantity, consistency, and other characteristics of secretions should be noted and recorded. When using an HME, if secretions become copious or appear increasingly tenacious, an HH should replace the HME.


*For the complete guideline, see American Association for Respiratory Care: Clinical practice guideline: humidification during mechanical ventilation, Respir Care 37:887, 1992.

Setting Humidification Levels

Although the American National Standards Institute (ANSI) recommends minimum levels of humidity for intubated patients (>30 mg/L), there is less guidance regarding appropriate settings for optimal humidification. One suggestion is to target the temperature and level of humidity for normal conditions at the point that the gas is entering the airway. For example, the humidity of air entering the carina is typically 35 to 40 mg/L. When humidifiers run too cold (<32° C), humidity can be reduced to the point of increased airway plugging. Not all active heated humidifiers perform the same under all conditions. Nishida40 compared the performance of four active humidifiers (MR290 with MR730 [Fisher & Paykel Healthcare Inc, Laguna Hills, CA], MR310 with MR730 [Fisher & Paykel Healthcare Inc], ConchaTherm IV [Hudson RCI, Temecula, CA], and Hummax II), which were set to maintain the temperature of the airway opening at 32° C and 37° C under various ventilator parameters. The greater the minute ventilation, the lower the humidity delivered with all devices except the Hummax II. When the airway temperature control of the devices was set at 32° C, the ConchaTherm IV, the MR 310, and the MR 730 all failed to deliver 30 mg/L of vapor, which is the value recommended by ANSI. This study emphasizes the need to set humidifiers to maintain airway temperatures between 35° C and 37° C.

Controversy exists regarding the appropriate temperature and humidity of inspired gas delivered to mechanically ventilated patients with artificial airways. The current AARC Clinical Practice Guideline recommends 33° C, within 2° C, with a minimum of 30 mg/L of water vapor. In a comprehensive review, Williams41 suggested that inspired humidity be maintained at an optimal level, 37° C with 100% relative humidity and 44 mg/L, to minimize mucosal dysfunction. Theoretically, optimal humidity offers improved mucociliary clearance. The benefits of this strategy are theory based but have yet to be shown conclusively in the clinical setting. Further controlled studies are needed to support better the need for optimal humidity.

Problem Solving and Troubleshooting

Common problems with humidification systems include dealing with condensation, avoiding cross contamination, and ensuring proper conditioning of the inspired gas.

Condensation

In all standard heated humidifier systems, saturated gas cools as it leaves the point of humidification and passes through the delivery tubing en route to the patient. As the gas cools, its water vapor capacity decreases, resulting in condensation or “rain out.” Factors influencing the amount of condensation include (1) the temperature difference across the system (humidifier to airway); (2) the ambient temperature; (3) the gas flow; (4) the set airway temperature; and (5) the length, diameter, and thermal mass of the breathing circuit.

Figure 35-10 provides an example of the condensation process. In this case, because of cooling along the circuit, the humidifier temperature has to be set to a higher level (50° C) than desired at the airway. At 50° C, the humidifier fully saturates the gas to an absolute humidity level of 84 mg/L of water. As cooling occurs along the tubing, the capacity of the gas to hold water vapor decreases. By the time the gas reaches the patient, the temperature of the gas has decreased to 37° C, and it is holding only 44 mg/L of water vapor. Although BTPS conditions have been achieved, 40 mg/L, half the total output of the humidifier (84 mg/L − 44 mg/L = 40 mg/L), has condensed in the inspiratory limb of the circuit.

The condensation process poses risks to patients and caregivers and can waste a lot of water. First, condensation can disrupt or occlude gas flow through the circuit, potentially altering fractional inspired oxygen (FiO2) or ventilator function or both. Condensate can work its way toward the patient and be aspirated. For these reasons, circuits must be positioned to drain condensate away from the patient and must be checked often, and excess condensate must be drained from heated humidifier breathing circuits on a regular basis.

Typically, patients contaminate ventilator circuits within hours, and condensate is colonized with bacteria and poses an infection risk.42 To avoid problems in this area, health care personnel should treat all breathing circuit condensate as infectious waste. See Chapters 4 and 43 for more detail on control procedures used with breathing circuits, including the AARC Clinical Practice Guideline on changing ventilator circuits (see Clinical Practice Guideline 4-1).

Several techniques are used to minimize problems with breathing circuit condensate. One common method is to place water traps at low points in the circuit (both the inspiratory and the expiratory limbs of ventilator circuits). This method aids drainage of condensate and reduces the likelihood of gas flow obstruction. When used in ventilator circuits, water traps should have little effect on circuit compliance, allow emptying without disrupting ventilation, and not be prone to leakage.

Nebulizers, with medication reservoirs below the aerosol generator and placed in the ventilator circuit, can act as a “water trap,” collecting contaminated condensate. There is a tremendous risk that contaminated aerosols can be generated and pathogens delivered to the deep lung. To minimize this risk, nebulizers should be placed in a superior position so that any condensate travels downstream from the nebulizer. In addition, these nebulizers should be removed from the ventilator circuit between treatments, rinsed and air dried, washed, and sterilized or disposed of and replaced.

One way to avoid condensation problems is to prevent condensation from forming. Because the decrease in temperature in gas traveling from the humidifier to the airway causes condensation, maintaining an appropriate temperature in the circuit can prevent formation of condensate. Several methods, such as insulation or increasing the thermal mass of the circuit, can reduce circuit cooling by keeping the circuit at a constant temperature. The most common approach uses wire heating elements inserted into the ventilator circuit.

Most heated wire circuits use dual controllers with two temperature sensors: one monitoring the temperature of gas leaving the humidifier and the other placed at or near the patient’s airway (Figure 35-11). The controller regulates the temperature difference between humidifier output and patient airway. When heated wire circuits are used, the humidifier heats gas to a lower temperature (32° C to 40° C) than with conventional circuits (45° C to 50° C). The reduction in condensate in the tubing results in less water use, reduced need for drainage, and less infection risk for patients and health care workers.

Even heated wire circuits can produce unwanted levels of condensate. One strategy is to provide absorptive material in the inspiratory limb of the ventilator circuit, which acts as a wick warmed by the heated wire system (Fisher & Paykel Healthcare Inc).

Use of heated wire circuits in neonates is complicated by the use of incubators and radiant warmers. Incubators provide a warm environment surrounding the infant and radiant warmers use radiant energy to warm objects that intercept radiant light. In both cases, a temperature probe placed in the heated environment would affect humidifier performance, resulting in reduced humidity received by the patient. Figure 35-12 shows the impact of temperature probe placement, in or out of the incubator, on absolute humidity delivered to the neonate. Consequently, temperature probes should always be placed outside of the radiant field or incubator (Figure 35-13).

Cross Contamination

Aerosol and condensate from ventilator circuits are known sources of bacterial colonization.42 However, advances in both circuit and humidifier technology have reduced the risk of nosocomial infection when these systems are used. Wick-type or membrane-type passover humidifiers prevent formation of bacteria-carrying aerosols. Heated wire circuits reduce production and pooling of condensate within the circuit. In addition, the high reservoir temperatures in humidifiers are bactericidal.43 In ventilator circuits using wick-type humidifiers with heated wire systems, circuit contamination usually occurs from the patient to the circuit, rather than vice versa.

For decades, the traditional way to minimize the risk of circuit-related nosocomial infection in critically ill patients receiving ventilatory support was to change the ventilator tubing and its attached components every 24 hours.44 It is now known that frequent ventilator circuit changes increase the risk of nosocomial pneumonia.45 Current research indicates that there is minimal risk of ventilator-associated pneumonia with weekly circuit changes and that there may be no need to change circuits at all.30,31,46,47 In addition, substantial cost savings can accrue with decreased frequency of circuit changes.

Proper Conditioning of Inspired Gas

All respiratory therapists (RTs) are trained to measure patient inspired FiO2 levels regularly and, in ventilatory care, to monitor selected pressures, volumes, and flows. However, few clinicians take the steps needed to ensure proper conditioning of the inspired gas received by patients.

The most accurate and reliable way to ensure that patients are receiving gas at the expected temperature and humidity level is to measure these parameters. Portable battery-operated digital hygrometer-thermometer systems are available for less than $300 and are invaluable in ensuring proper conditioning of the inspired gas. When measuring high-humidity environments, hygrometers become saturated and nonresponsive over time and so should be used for spot checks only. These devices should be as common at the bedside as O2 analyzers.

Many heated wire humidification systems have a humidity control. This control does not reflect either absolute or relative humidity but only the temperature differential between the humidifier and the airway sensor. If the heated wires are set warmer than the humidifier, less relative humidity is delivered to the patient. To ensure that the inspired gas is being properly conditioned, clinicians should always adjust the temperature differential to the point that a few drops of condensation form near the patient connection, or “wye.” Lacking direct measurement of humidity, observation of this minimal condensate is the most reliable indicator that the gas is fully saturated at the specified temperature. If condensate cannot be seen, there is no way of knowing the level of relative humidity without direct measurement—it could be anywhere between 99% and 0%. HME performance can be evaluated in a similar manner.48

Bland Aerosol Therapy

Humidity is simply water in the gas phase, whereas a bland aerosol consists of liquid particles suspended in a gas (see Chapter 36 for details on aerosol physics). Bland aerosol therapy involves the delivery of sterile water or hypotonic, isotonic, or hypertonic saline aerosols. Bland aerosol administration may be accompanied by O2 therapy. To guide practitioners in applying this therapy, the AARC has published Clinical Practice Guideline: Bland Aerosol Administration; excerpts appear in Clinical Practice Guideline 35-2.49

35-2   Bland Aerosol Administration

AARC Clinical Practice Guideline (Excerpts)*


*For the complete guideline, see Kallstrom T: American Association for Respiratory Care: AARC clinical practice guideline. Bland aerosol administration—2003 revision and update, Respir Care 48:529, 2003.

Equipment for Bland Aerosol Therapy

The equipment needed for bland aerosol therapy includes an aerosol generator and a delivery system. Devices used to generate bland aerosols include large volume jet nebulizers and ultrasonic nebulizers (USNs). Delivery systems include various direct airway appliances and enclosures (mist tents).

Aerosol Generators

Large Volume Jet Nebulizers

A large volume jet nebulizer is the most common device used to generate bland aerosols. As depicted in Figure 35-14, these devices are pneumatically powered, attaching directly to a flowmeter and compressed gas source. Liquid particle aerosols are generated by passing gas at a high velocity through a small “jet” orifice. The resulting low pressure at the jet draws fluid from the reservoir up to the top of a siphon tube, where it is sheared off and shattered into liquid particles. The large, unstable particles fall out of suspension or impact on the internal surfaces of the device, including the fluid surface (baffling). The remaining small particles leave the nebulizer through the outlet port, carried in the gas stream. A variable air-entrainment port allows air mixing to increase flow rates and to alter FiO2 levels (see Chapter 38).

Similar to humidifiers, if heat is required, a hot plate, wraparound, yolk collar, or immersion element can be added. However, in contrast to heated humidifiers, these devices rarely have sophisticated servo-controlled systems to control delivery temperature. Many systems do not shut down when the reservoir empties, resulting in the delivery of hot, dry gas to the patient. Failure of the element can also cause a loss of heating capacity, without warning to the clinician.

Depending on the design, input flow, and air-entrainment setting, the total water output of unheated large volume jet nebulizers varies between 26 mg H2O/L and 35 mg H2O/L. When heated, output increases to between 33 mg H2O/L and 55 mg H2O/L, mainly because of increased vapor capacity.49,50 Larger versions of these devices (with 2-L to 3-L reservoirs) are used to deliver bland aerosols into mist tents. These enclosure systems can generate flow rates faster than 20 L/min, with water outputs of 5 ml/min (300 ml/hr). Because heat buildup in enclosures is a problem, these systems are always run unheated.

Ultrasonic Nebulizers

A USN is an electrically powered device that uses a piezoelectric crystal to generate aerosol. This crystal transducer converts radio waves into high-frequency mechanical vibrations (sound). These vibrations are transmitted to a liquid surface, where the intense mechanical energy creates a cavitation in the liquid, forming a standing wave, or “geyser,” which sheds aerosol droplets. Figure 35-15 provides a schematic of a large volume USN. Output from a radiofrequency generator is transmitted over a shielded cable to the piezoelectric crystal. Vibrational energy is transmitted either indirectly through a water-filled couplant reservoir or directly to a solution chamber. Gas entering the chamber inlet picks up the aerosol particles and exits through the chamber outlet.

The properties of the ultrasonic signal determine the characteristics of the aerosol generated by these nebulizers. The frequency at which the crystal vibrates, preset by the manufacturer, determines aerosol particle size. Particle size is inversely proportional to signal frequency. A USN operating at a frequency of 2.25 MHz may produce an aerosol with a mass median aerodynamic diameter (MMAD) of approximately 2.5 µm, whereas another nebulizer operating at 1.25 MHz produces an aerosol with MMAD between 4 µm and 6 µm. Signal amplitude directly affects the amount of aerosol produced; the greater the amplitude, the greater the volume of aerosol output. In contrast to frequency, signal amplitude may be adjusted by the clinician.

Particle size and aerosol density delivered to the patient are also affected by the source and flow of gas through the aerosol-generating chamber. Some large volume USNs have built-in fans that direct room air through the solution chamber conducting the aerosol to the patient. The airflow may be adjusted by changing the fan speed or use of a simple damper valve. Alternatively, compressed anhydrous gases can be delivered to the chamber inlet through a flowmeter. For precise control over delivered O2 concentrations, clinicians can attach a flowmeter with an O2 blender or air-entrainment system to the chamber inlet.

The flow and amplitude settings interact to determine aerosol density (mg/L) and total water output (ml/min). Amplitude affects water output. At a given amplitude setting, the greater the flow through the chamber, the less the density of the aerosol. Conversely, low flows result in aerosols of higher density. Total aerosol output (ml/min) is greatest when both flow and amplitude are set at the maximum. Using these settings, some units can achieve total water outputs of 7 ml/min.

Particle size, aerosol density, and output are also affected by the relative humidity of the carrier gas (see Chapter 36). In contrast to jet nebulizers, the temperature of the solution placed in a USN increases during use. Although this increase in temperature affects water vapor capacity, its impact on aerosol output is minimal.

Although USNs have some unique capabilities, in most cases of bland aerosol administration, their relative advantages over jet nebulizers are outweighed by their high cost and erratic reliability. Exceptions include the use of a USN for sputum induction, where the high output (1 to 5 ml/min) and aerosol density seem to yield higher quantity and quality of sputum specimens for analysis, although at some cost in increased airway reactivity.51 Although a major manufacturer of USNs (DeVilbiss) discontinued their product line, other manufacturers in both the United States and Europe still manufacture units for clinical use.

Commercially available USNs (usually marketed as “cool” mist devices) have found a place in the home, being used as room humidifiers. As with any nebulizer, the reservoirs of these devices can easily become contaminated, resulting in airborne transmission of pathogens. Care should be taken to ensure that these units are cleaned according to the manufacturer’s recommendations and that water is discarded from the reservoir periodically between cleanings. In the absence of a manufacturer’s recommendation, these units should undergo appropriate disinfection at least every 6 days.52 Generally, passover and wick-type humidifiers present less risk than the USN as a room humidifier.

Airway Appliances

Airway appliances used to deliver bland aerosol therapy include aerosol mask, face tent, T-tube, and tracheostomy mask (Figure 35-16). The aerosol mask and face tent are used for patients with intact upper airways. The T-tube is used for patients who are orally or nasally intubated or who have a tracheostomy. The tracheostomy mask is used only for patients who have a tracheostomy. In all cases, large bore tubing is required to minimize flow resistance and prevent occlusion by condensate.

For short-term therapy to patients with intact upper airways, the aerosol mask is the device of choice. However, some patients cannot tolerate masks and may do better with a face tent. No data support preferential use of an open aerosol mask versus a face tent.

Although the T-tube is the most common application for tracheostomy patients, unless moderate to high FiO2 levels are needed, a tracheostomy mask is a better choice. In contrast to T-tubes, tracheostomy masks exert no traction on the airway, and they allow secretions and condensate to escape from the airway, reducing airway resistance.

Enclosures (Mist Tents and Hoods)

Infants and small children may not readily tolerate direct airway appliances such as masks, so enclosures such as mist tents and aerosol hoods are used to deliver bland aerosol therapy to these patients. More recent studies have shown that aerosol hoods can provide aerosol delivery with similar efficiency to a properly fitted aerosol mask in infants, with less discomfort for the patient.53

Because mist tents were used for more than 40 years mainly to treat croup, clinicians may still refer to these devices as croup tents. The cool aerosol provided through these enclosures promotes vasoconstriction, decreases edema, and reduces airway obstruction.

Any body enclosure poses two problems: carbon dioxide (CO2) buildup and heat retention. CO2 buildup can be reduced by providing sufficiently high gas flow rates. These high flows of fresh gas circulate continually through the enclosure and “wash out” CO2, while helping maintain desired O2 concentrations. Heat retention is handled differently by each manufacturer. Some devices use high fresh gas flows to prevent heat buildup. Others incorporate a separate cooling device. Some tent devices use a simple ice compartment to cool the aerosol. The Ohmeda Ohio Pediatric Aerosol Tent (Ohmeda Ohio Corp., Gurnee, IL) and other similar units use electrically powered refrigeration units to cool the circulating air.

The cooling from these refrigeration units produces a great deal of condensation, which must be drained into a collection bottle outside of the tent. Units such as the Mistogen CAM-3M have overcome some of these problems with a thermoelectric cooling system, in which an electrical current passing through a semiconductor augments heat absorption and release. As warm air is taken from the tent, heat is transferred and released in the room, and cool air is returned to the tent.

Sputum Induction

As a diagnostic procedure, sputum induction (Box 35-5) warrants separate attention from other modes of bland aerosol therapy. Over the years, sputum induction has proved a useful, cost-effective, and safe method for diagnosing tuberculosis, pneumocystis pneumonia (caused by Pneumocystis jiroveci [formerly Pneumocystis carinii]), and lung cancer.5456

Box 35-5

Sputum-Induction Procedure

Gather the necessary equipment: USN, aerosol mask, large bore tubing, specimen container, 3% sterile saline, and stethoscope.

Check the chart for order or protocol, diagnosis, history, and other pertinent information.

Wash your hands and follow applicable standard, airborne, and tuberculosis precautions.

Introduce yourself and identify your department; verify the patient’s identity; and explain the procedure and verify that the patient understands it.

Have the patient assume an upright, seated position if possible.

Have the patient rinse his or her mouth with water, blow his or her nose, and clear any excess saliva.

Perform pretreatment assessment, including vital signs, muscle tone, ability to cough, and auscultation.

Assemble the nebulizer; fill the couplant chamber with tap water; plug the unit into a grounded electrical outlet; and attach the delivery tubing and mask.

Aseptically fill the medication chamber of the nebulizer with 3% sterile saline.

Turn the unit on, and adjust the output control to achieve adequate flow and high density.

Place the mask comfortably on the patient’s face, and instruct the patient to take slow, deep breaths, with occasional inspiratory hold as tolerated.

Periodically reassess the patient’s condition (including breath sounds) throughout the application.

Modify the technique and reinstruct the patient as needed, based on his or her response.

Terminate the treatment after 15 to 30 minutes, if significant adverse reactions occur, or when sputum specimen has been obtained.

Encourage the patient to cough and expectorate sputum into specimen cup; observe for volume, color, consistency, odor, and presence or absence of blood.

Label the specimen container with patient identification and required information, and deliver to the appropriate personnel.

Chart the therapy according to departmental and institutional protocol.

Notify the appropriate personnel of any adverse reactions or other concerns.

Modified from Butler TJ: Laboratory exercises for competency in respiratory care, ed 2, Philadelphia, 2009, FA Davis.

Sputum induction involves short-term application of high-density hypertonic saline (3% to 10%) aerosols to the airway to assist in mobilizing pulmonary secretions for evacuation and recovery. These high-density aerosols are most easily generated using ultrasonic nebulization. The exact mechanism by which high-density hypertonic aerosols aid mucociliary clearance is unknown. However, an increased volume of surface fluid delivered to the airways, combined with stimulation of the irritant (cough) reflex, is a likely mechanism.

Box 35-5 outlines a procedure for sputum induction using a 3% saline solution.57 To ensure a good sputum sample, every effort must be made to separate saliva from true respiratory tract secretions.56 In some cases, protocols include having patients brush their teeth and tongue surface thoroughly and rinse their mouths before sputum induction. Although the distinction between saliva and sputum can be made in the diagnostic laboratory, care during the collection procedure eliminates the need for repeat inductions.

Problem Solving and Troubleshooting

The most common problems with bland aerosol delivery systems are cross contamination and infection, environmental safety, inadequate mist production, overhydration, bronchospasm, and noise.

Cross Contamination

Rigorous adherence to the infection control guidelines detailed in Chapter 4, especially guidelines covering solutions and equipment processing, should help minimize the cross contamination and infection risks involved in using these systems. In addition, the water should be changed regularly, and the couplant compartments and nebulizer chambers of USNs should be disinfected or replaced regularly.

Environmental Exposure

Environmental safety issues from secondhand and exhaled aerosol arise mainly when aerosol therapy is prescribed for immunosuppressed patients or for patients with tuberculosis. A survey suggested that RTs may be at increased risk for developing asthma-like symptoms, attributed partly to secondhand exposure to aerosols such as ribavirin or albuterol.58 To minimize problems in this area, all clinicians should strictly follow U.S. Centers for Disease Control and Prevention standards and airborne precautions, including precautions specified for control of exposure to tuberculosis (see Chapter 4). Additional methods for dealing with environmental control of drug aerosols are described in Chapter 36.

Inadequate Aerosol Output

Inadequate mist production is a common problem with all nebulizer systems. With pneumatically powered jet nebulizers, poor mist production can be caused by inadequate input flow of driving gas, siphon tube obstruction, or jet orifice misalignment. With the exception of inadequate driving gas flow, these problems require unit repair or replacement. If a USN is not functioning properly, the electrical power supply (cord, plug, and fuse or circuit breakers) should be checked first. The clinician next should check to confirm that (1) carrier gas is flowing through the device and (2) the amplitude, or output, control is set above minimum. If there is still no visible mist output, the clinician should inspect the couplant chamber to confirm proper fill level and the absence of any visible dirt or debris. Finally, the clinician must ensure that the couplant chamber solution meets the manufacturer’s specifications (most units do not function properly with distilled water).

Overhydration

Overhydration is a problem with continuous use of heated jet nebulizers and USNs. With USNs capable of such extraordinarily high water outputs, they should never be used for continuous therapy. The risk of overhydration is highest for infants, small children, and patients with preexisting fluid or electrolyte imbalances. Even if used only to meet BTPS conditions, bland aerosol therapy effectively eliminates insensible water loss through the lungs and should be equated to a daily water gain (approximately 200 ml/day for an average adult). In addition to overhydration of the patient, inspissated pulmonary secretions can swell after high-density aerosol therapy, worsening airway obstruction. Careful patient selection and monitoring can prevent most potential problems with overhydration.

Bronchospasm

Even bland water aerosols can cause bronchospasm in some patients. Ultrasonic nebulization of distilled water is used in some pulmonary function laboratories to provoke bronchospasm and to assess bronchial hyperactivity.57 To avoid this problem at the bedside, the clinician should always carefully review the patient’s history and diagnosis before administering any bland aerosol, especially a hypotonic water solution. As indicated in the AARC practice guideline (see Clinical Practice Guideline 35-2), patients receiving continuous bland aerosol therapy should be initially monitored carefully (including breath sounds and subjective response) and reevaluated every 8 hours or with any change in clinical condition.49 If bronchospasm occurs during therapy, treatment must be stopped immediately, O2 must be provided, and appropriate bronchodilator therapy should be initiated as soon as possible. If the physician still requests bland aerosol therapy for such a patient, pretreatment with a bronchodilator may be needed. In addition, isotonic solutions (0.9% saline) may be better tolerated by these patients than water.

A problem unique to large volume, air entrainment jet nebulizers is the noise they generate, especially at high flows. The American Academy of Pediatrics recommends that sound levels remain less than 58 dB to avoid hearing loss for infants being cared for in incubators and O2 hoods. Because many commercial nebulizers exceed this noise level when in operation, careful selection of equipment is necessary. However, the best way to avoid this problem and minimize infection risks further is to use heated passover humidification instead of nebulization.

Selecting The Appropriate Therapy

Figure 35-17 provides a basic algorithm for selecting or recommending the appropriate therapy to condition a patient’s inspired gas. Key considerations include (1) gas flow, (2) presence or absence of an artificial tracheal airway, (3) character of the pulmonary secretions, (4) need for and expected duration of mechanical ventilation, and (5) contraindications to using an HME.

Regarding delivery of O2 to the upper airway, the American College of Chest Physicians advises against using a bubble humidifier at flow O2 rates of 4 L/min or less.59 For the occasional patient who complains of nasal dryness or irritation when receiving low-flow O2, a humidifier should be added to the delivery system. Conversely, the relative inefficiency of unheated bubble humidifiers means that the clinician may need to consider heated humidification for patients receiving long-term O2 at high flow rates (>10 L/min without air entrainment).

HMEs provide an inexpensive alternative to heated humidifiers when used for ventilation of patients who do not have complex humidification needs. However, passive HMEs may not provide sufficient heat or humidification for long-term management of certain patients. When an HME is to be used, it should be selected based on individual patient need and ventilatory pattern and the unit’s performance, efficiency, and size. All patients using HMEs should be reevaluated regularly to confirm the appropriateness of continued use.60

Mini Clini

Cost-Effectiveness of Humidification Systems

Solution

First, determine the frequency of circuit setup and component changes for each type of humidification system. Second, determine supplies and time required to set up the system and to operate the system on a daily basis.

The following table compares the costs associated with three humidification strategies in terms of circuit setup costs, water usage, and labor for a typical patient requiring 12 days of mechanical ventilation at a large, comprehensive acute care hospital. Labor costs were calculated as the time required to perform setup or maintenance multiplied by the average salary. This example assumes no circuit changes for a patient over 14 days and that the HME is changed daily.

Components of Circuit Setup and Operating Costs Heated Humidifier With Standard Circuit Heated Humidifier With Heated Wire Circuit Heat Moisture Exchanger
Vent circuit $3.00 $11.00 $3.00
Humidifier/water feed system $12.00 $12.00
HME filter $5.00
Setup cost (labor) $18.00 $23.00 $8.00
Daily cost (labor) $11.00 $1.50 $5.00
Total costs (5 days) $62.00 $29.00 $28.00
Total costs (12 days) $139.00 $39.50 $63.00

image

In this example, the standard circuit costs less than the heated wire circuit but has twice the daily water usage, with an additional labor cost of $9.50 per day for adding and removing water from the system. The HME has the lowest setup cost, but after ventilator day 5, total costs of daily filter replacement exceed the cost associated with operation of the heated wire circuit. Although different component costs may shift the analysis, this example shows that use of active humidity employing heated wire circuits is more cost-effective than standard circuits and possibly even HMEs.

Summary Checklist

• Conditioning of inhaled and exhaled gas is accomplished primarily by the nose and upper airway. Bypassing the upper airway without providing similar levels of heat and humidity to inhaled gas can cause damage to the respiratory tract.

• The primary goal of humidification is to maintain normal physiologic conditions in the lower airways.

• Gases delivered to the nose and mouth should be conditioned to 20° C to 22° C with 10 mg/L water vapor (50% relative humidity).

• When being delivered to the trachea, gases should be warmed and humidified to 32° C to 40° C with 36 to 40 mg/L water vapor (>90% relative humidity).

• A humidifier is a device that adds invisible molecular water to gas.

• A nebulizer generates and disperses liquid particles in a gas stream.

• Water vapor cannot carry pathogens, but aerosols and condensate can carry pathogens.

• Temperature is the most important factor affecting humidifier output. The higher the temperature, the greater the water vapor content of the delivered gas.

• Bubble humidifiers, passover humidifiers, wick humidifiers, and HMEs are the major types of humidifiers. Active humidifiers incorporate heating devices and reservoir and feed systems.

• At high flow rates, some bubble humidifiers can produce microaerosol particles, which can carry infectious bacteria.

• Most HMEs are passive, capturing both heat and moisture from expired gas and returning it to the patient, at about 70% efficiency. HMEs are not recommended for use with infants because of the increased mechanical dead space and use of uncuffed endotracheal tubes, which allow some exhaled gas to bypass the HME.

• Common problems with humidification systems include condensation, cross contamination, and ensuring proper conditioning of the inspired gas.

• Breathing circuit condensate must always be treated as infectious waste.

• Bland aerosol therapy with sterile water or saline is used to (1) treat upper airway edema, (2) overcome heat and humidity deficits in patients with tracheal airways, and (3) help obtain sputum specimens.

• Large volume jet nebulizers and USNs are used to generate bland aerosols. Delivery systems include various direct airway appliances and mist tents.

• Common problems with bland aerosol therapy are cross contamination and infection, environmental safety, inadequate mist production, overhydration, bronchospasm, and noise.

Share this: